Insulin analogues in type 1 diabetes mellitus: getting better all the time.
about
FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice.Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase 3 trial.Hope vs hype: where are we in type 1 diabetes?Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action.Probing the correlation between insulin activity and structural stability through introduction of the rigid A6-A11 bond
P2860
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
@en
type
label
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
@en
prefLabel
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
@en
P2860
P356
P1476
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
@en
P2093
Katrien Benhalima
P2860
P2888
P304
P356
10.1038/NRENDO.2017.39
P577
2017-04-21T00:00:00Z